INTRODUCTION
The human -globin gene cluster on chromosome 11 consists of five developmentally specific genes for embryonic ( ), fetal ( G , A ) and adult ( , ) globins.
A strong enhancer, located in the far upstream region of the cluster called the locus control region (LCR), contains five DNase I hypersensitive (HS) sites, and is able to enhance tissue-specific globin gene expression and provide a high level of transcription activity from human globin gene constructs in transgenic mice. Transcription factors such as EKLF, GATA-1 and NF-E2, that bind to the LCR and other regulatory elements, and promoters in the globin gene locus, have been reported to regulate chromatin histone acetylation by associating with histone acetyltransferases [1] [2] [3] . The LCR is required to increase the rate of transcription, but may be dispensable for formation of an open chromatin domain of a downstream active globin gene in erythroid cells 4, 5 . For globin gene expression, spatial organization of the -globin cluster requires special interactions between distal transcriptional elements in the LCR and downstream active globin genes.
Some developmental specificity between individual hypersensitive sites in the LCR and downstream globin genes is evident such as the interaction between HS2 and -globin for transcription activation 6 .
Complex packaging of eukaryotic chromosomes in nuclei creates chromatin loops and matrix/scaffold attachment regions (MARs/SARs; the term MARs is used here), originally identified as genomic DNA fragments that remain tightly associated with saltextracted and DNase 1 digested nuclei, have been postulated to be localized at the base of chromatin loops 7 . MARs identified by such criteria often contain a base-unpairing region (BUR), the DNA bases of which become continuously unpaired when subjected to negative superhelical strain 8, 9 . Many candidate MARs in the -globin cluster appear to be in regions of mass binding sites for transcription factors, some of which are developmental stage-specific 10, 11 . MARs found flanking the -or -globin genes or only.
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SATB1 binds to double-stranded BUR sequences, specifically recognizing a specialized DNA context (an ATC sequence context), characterized by a cluster of sequence stretches with well mixed As and Ts but either Cs or Gs exclusively on one strand (designated as ATC sequences) 17 . SATB1 has roles in tissue-specific organization of DNA sequences, in regulation of gene expression by acting as a "landing platform" for chromatin remodeling enzymes, and in designation of the region-specific histone modification in vivo 18, 19 . In vitro studies have indicated that SATB1 family protein can bind to some of the MARs in the -globin gene cluster 12, 14, 15 . Here, we show that overexpression of SATB1 in K562 cells induces hemoglobin and globin gene expression concomitant with changes in chromatin structure, and that SATB1 interacts directly with
MARs in vivo in the -globin cluster at LCR HS2 and at the -globin promoter region.
These data suggest that during early erythroid development SATB1 may provide previously unknown mechanism underlying differential globin gene regulation.
only.
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MATERIAL AND METHODS

Cell culture
Human erythroleukemia K562 cells (American Type Culture Collection, Manassas, VA) were cultured in RPMI 1650/10% FBS 20 . Human primary erythroid progenitor cells were purified using Ficoll-Hypaque (BioWhittaker, Walkersville, MD) from blood obtained from consenting normal volunteers through the NIH Department of Transfusion Medicine and cultured as described 21 . Approval was obtained from the National Institutes of Health institutional review board for these studies. Informed consent was provided according to the Declaration of Helsinki.
Cell transfection
A SATB1 expression vector was constructed by excising SATB1 cDNA (EcoR1) from pECHAT1146 17 , ligating into pIRES2-EGFP (Clontech, Palo Alto, CA) to give pEGFP/SATB1, and accuracy confirmed by DNA sequencing. For stable cell lines, pEGFP/SATB1 or pIRES2-EGFP was transfected by electroporation into K562 cells 22 .
Clones were selected using geneticin (500 µg/ml) (Gibco, Grand Island, NY). For reporter gene assays, 5.0 X 10 5 HeLa cells or 5.0 X 10 6 K562 cells were transfected using Superfect reagent (Qiagen, Valencia, CA). After 72 hr, cells were harvested and assayed.
PSV--Galactosidase (Promega, Madison, WI) was co-transfected for normalization of transfection efficiency. CBP (RSVCBP), E1A and a mutant E1A (E1A 2-36), and SATB1 (pEGFP/SATB1) expression vectors were used for co-transfection with reporter gene constructs. pEGFP/SATB1 was transfected into primary erythroid progenitor cells by electroporation.
Reporter gene construction
The -globin promoter with the 5' flanking M MAR (-445 to +17) or without (-365 to +17) was inserted between the KpnI and Hind III sites of the reporter vector 
RNA isolation and quantitative RT-PCR analysis
Total RNA was isolated and first-strand cDNA was synthesized using MuLV reverse transcriptase and oligo-d (T) 16 (PE Applied Biosystems, Foster City, CA). For quantitative real-time PCR analysis, gene-specific primers and fluorescent labeled TaqMan probes (6-carboxy fluorescein (FAM) as the 5' fluorescent reporter, tetramethylrhodamine (TAMRA) as 3' end quencher) were used in a 7700 Sequence Detector (Applied Biosystems, Foster City, CA) as described 24 . All results were normalized to human -actin.
Western blot analysis
Cell lysates were obtained by adding RIPA buffer (10 mM Tris HCl, 1 mM EDTA, 0.1% SDS, 0.1% Na 3 VO 4 , 1% Triton-X 100) and protease inhibitor (Roche Diagnostics GmbH Mannheim, Germany) into the cell pellet, incubated on ice for 30 min and centrifuged at 13000 rpm for 10 min. The protein sample was run on NuPAGE TM 4-only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From 12% Bis-Tris Gel (Invitrogen, Carlsbad, CA) for 1 hr at 200 V. Protein was transferred to nitrocellulose by standard methods. The blot was blocked with 5% nonfat milk in TTBS buffer (Tween 20 Tris buffered saline) for 1 hr at room temperature, probed with primary antibody for 1 hr at room temperature, washed in TTBS buffer, probed with HRPconjugated secondary antibody for 1 hr at room temperature, and rinsed in TTBS buffer for chemiluminescent detection.
Nuclear extract isolation and DNA binding assay K562 and K562/SATB1 nuclear extracts were prepared for electromobility shift assay (EMSA). Nuclei were extracted from washed cells using hypotonic buffer (10 mM HEPES, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT, and 0.5 mM PMSF) and centrifuged. The cytoplasm containing supernatant was discarded, the pellet resuspended in 2X volume of extraction buffer (20 mM HEPES, 25% glycerol, 0.42 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF), placed on ice for 30 min and centrifuged (10,000rpm; 10 min), and the supernatant containing the nuclear extract collected. For EMSA, DNA probes were labeled with -32 P-ATP by reaction with T4 polynucleotide kinase (New England BioLabs Inc., Beverly, MA). Probe binding to nuclear extract was carried out at room temperature for 30 min in binding buffer (20 mM Tris HCL (pH 8), 100 mM NaCl, 1 mM EDTA, 5% NP-40, 10 mM dithiothreitol and 0.1 mg/µl bovine serum albumin). DNA-protein complexes were visualized using electrophoresis in a 4% non-denaturing polyacrylamide gel and autoradiography. For GATA-1 EMSA, reaction buffer contained 10 nM HEPES, 50 nM potassium glutamate, 5 mM MgCl 2 , 1 mM EDTA, 2 mM dithiothreitol, 5% glycerol and 1 µg of poly(dI-dC).
Chromatin immunoprecipitation
Chromatin extracts were prepared as described 25 . In brief, 2 X 10 7 cells were fixed with formaldehyde and incubated at 37 ºC for 3 min, washed in PBS, resuspended only.
Co-immunoprecipitation
K562 nuclear extract (100 µg) was incubated with SATB1 or CBP antibodies, or preimmune serum and protein A-Agarose (Santa Cruz, Biotechnology Inc., Santa Cruz, California) in 1 ml of binding buffer (0.5% NP-40, 10 mM Tris HCL, 150 mM NaCl, 2 mM EDTA, 10% glycerol, Protease inhibitor) for 3 hr at 5°C. The reaction mixture was briefly centrifuged, the pellet washed in 1 ml binding buffer three times at 5°C for 5 min., and the immunoprecipitated SATB1/CBP or CBP/SATB1 complexes were separated on a polycrylamide gel. Anti-SATB1 or anti-CBP antibody was used for Western blot analysis of bound proteins.
Treatment with antisense oligonucleotide
SATB1 sense and antisense oligonucleotides flanking the translation start site (5'-GCCTCGTTCAAATGATCCATACTCAGTC-3') were synthesized with a phosphorothioate backbone and purified by HPLC (Synthegen, Houston, TX). Fresh antisense or sense (control) oligonucleotide was added to the primary erythroid progenitor cells at day 1 and day 3 of phase II culture and the cells harvest at day 5. 
Statistical methods
Statistical
RESULTS
SATB1 increases embryonic globin production
To investigate the influence of SATB1 on globin gene regulation, a SATB1 expression vector was stably transfected into K562 cells which endogenously express a low level (compared with T-lymphocytes) of SATB1 (or its isoform) 14, 27 , to generate K562/SATB1. Western blotting confirmed the increase in SATB1 expression ( Figure   1A )
. Surprisingly, a red cell pellet clearly indicated a marked elevation in hemoglobin production in the K562/SATB1 cells without hemin ( Figure 1A ). Benzidine staining shows hemoglobinization increasing from 4% (control K562 population) to 48% in the K562/SATB1 cells ( Figure 1B ). Additional stable K562/SATB1 clones were isolated and analyzed. SATB1 levels, determined by Western blotting, correlated with hemoglobin production measured spectrophotometrically ( Figure 1C ). Since globin expression is primarily transcriptionally regulated, quantification of globin mRNA reflects the amount of globin produced. Globin gene expression was determined using gene specific primers and Taqman probes (Table 1) . K562 cells express predominantly -and -, and low levels of -globin mRNA ( Figure 1D ). Quantitative RT-PCR analysis indicated that overexpression of SATB1 increased -globin transcripts to 250% compared to stable transfection with the vector control (mock) and reduced -globin transcripts while leaving -globin unchanged ( Figure 1D ). Induction of corresponding hemoglobin was confirmed by HPLC. SATB1 increased -globin gene expression in a dose-dependent manner ( Figure 1E ).
We previously showed that increasing GATA-1 in K562 cells decreases -globin expression, while increasing GATA-2 increases -and -globin expression 28 . SATB1 did not affect GATA-1 or GATA-2 production. Western blot analysis of K562, K562/SATB1
and K562 mock cells showed comparable amounts of GATA-1 and GATA-2 ( Figure 1F ).
EMSA determined GATA-1 binding in nuclear extract from K562 cells and several clones of K562/SATB1 cells and indicated that increasing SATB1 only modestly affected only.
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Hemin-induced erythroid differentiation
Hemin induction of K562 cell erythroid differentiation increases hemoglobin production and -globin gene expression 32 . Using hemin induced K562 nuclear extract for EMSA, protein binding to the SATB1 probe (S), Wt (25) only.
SATB1 interacts with MARs localized in the -globin cluster in vivo
To identify new SATB1 binding sites in the -globin locus in addition to those previously reported in this region, we examined SATB1 binding to potential MAR sequences from HS2 and the 5' flanking region of the -globin gene (Figure 3A ) 13 . Using the potential MAR at the 5' region of HS2 (HS2-M1:
CATTATAATTAACTGTTATTTTTTA, located 158 bp upstream of Hind III in the HS2 core) as a DNA probe for EMSA, we observed a slow migrating band from the K562 nuclear extract ( Figure 3B lanes 1-4) . This band was competed by the SATB1 binding sequence Wt (25) 
the -globin promoter, as expected for transcription activation and the marked increase in -globin expression ( Figure 5C ).
CBP increases SATB1 transcriptional activity
CBP/p300 is known to interact with a variety of DNA-binding transcription factors and to possess intrinsic histone acetyltransferase activity 36, 37 . CBP cooperates with GATA-1 and is required for erythroid differentiation 38 . Using coimmunoprecipitation analysis and antibodies specific for SATB1 and CBP, we found that a complex containing CBP and SATB1 in K562 cells could be immunoprecipitated by both CBP and SATB1 specific antibodies but not by preimmune serum ( Figure 6A , lanes 1-6). In contrast, no SATB1 and p300 protein complex in K562 cells was detected ( Figure 6 , lane 8). E1A is known to be able to repress CBP transcriptional activity and has been used to test the requirement of CBP 39 . In K562 cells, cotransfection of pEGFP/SATB1 and an E1A expression vector with pREP4/ abrogated the increase in reporter gene activity observed with cotransfection of pEGFP/SATB1 alone with pREP4/ ( Figure 6B ). There was no inhibition of luciferase activity when using the mutant E1A 2-36. In the presence of SATB1, CBP exhibited a dose dependent increase in pREP4/ reporter gene activity ( Figure 6C ), while cotransfection of increasing amounts of the CBP expression construct with the pREP4/ reporter gene in the absence of pEGFP/SATB1 showed little change in transcription activity ( Figure 6D ). These results provide evidence that SATB1 and the transcription coactivator, CBP, are in the same protein complex that is functionally important for -globin expression and that CBP enhances SATB1-mediated transcriptional activity. Reporter gene assays in HeLa cells exhibited comparable inhibition by E1A of SATB1 activity on the -globin promoter with no effect on the mutant E1A 2-36 ( Figure 6E ). The dose dependent enhancement by CBP of SATB1 activation of the -globin promoter was also observed in HeLa cells ( Figure 6F ) providing additional evidence for participation of SATB1 and CBP in a only.
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Human primary erythroid protenitor cells
To determine expression of SATB1 during erythroid differentiation of human adult erythroid progenitor cells, human primary hematopoietic progenitor cells were isolated from peripheral blood and stimulated for erythroid differentiation. Western blotting with anti-SATB1 antibody detected protein early during erythroid differentiation at day 5 of erythropoietin stimulation ( Figure 7A ). By day 8 with erythropoietin, this protein band was markedly decreased to low levels. We have previously shown -globin gene activation during early adult erythropoiesis 20 . Analysis of -like globins in these cultures revealed that the peak -globin expression at day 5 following erythropoietin stimulation coincided with the peak in reactivity to anti-SATB1 antibody and markedly decreased by day 8 of erythropoietin stimulation, while -globin expression continued to increase ( Figure 7B ). The induction of -globin gene expression followed and then surpassed -globin gene expression late in erythroid differentiation ( Figure 7B ). These data show a possible correlation between -globin gene expression and SATB1 family protein expression.
To investigate the effect of SATB1 on globin gene transcription, a SATB1 expression vector was transfected into human primary adult erythroid progenitor cells, and the cells were harvested at day 8. Maintaining SATB1 expression at a high level beyond day 5 resulted in an increase in -globin expression (3-fold) with a reduction inglobin expression (3-fold) ( Figure 7C ). These changes in -globin and -globin expression are concomitant with increases in histone H3 and H4 acetylation in theonly.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From globin promoter and with decreases in histone H3 and H4 acetylation in the -globin promoter ( Figure 7D ). These data suggest that, as observed in K562 cells, manipulation of the SATB1 level during differentiation of adult early erythroid progenitor cells can alter chromatin associated with -globin and -globin and change the balance of globin gene expression, particularly between -globin and -globin. To down regulate SATB1 family protein expression, a SATB1 antisense oligonucleotide was synthesized.
Transfection into cells down regulated anti-SATB1 immunoreactive protein when compared with the sense control ( Figure 7E ). As observed with hemin induction in K562 cells, the antisense oligonucleotide resulted in a decrease in SATB1, a decrease inglobin, and an increase in -globin expression compared with the sense control ( Figure   7E ). 40 and can target multiple chromatin-remodeling complexes to specific genomic sites in order to regulate chromatin structure 18 . We found that SATB1 family protein which is expressed in K562 cells 27 is down regulated by hemin induction which is concomitant with increased -globin expression and decreased -globin expression. Conversely, increased SATB1 expression in transfected K562 cells results in activation of -globin and a decrease in -globin expression, with a marked induction of total hemoglobin production in the absence of hemin.
Transcription factors, such as GATA-1 and NF-E2, and EKLF for -globin expression, can interact specifically within the -globin cluster at the LCR and down stream globin genes, and can associate with histone acetylases to modify chromatin structure to activate globin gene transcription. In vivo SATB1 binding genomic sites are tightly associated with the base of chromatin loops 41 . Linkage between SATB1 and globin gene expression was initially suggested by the discovery of SATB1 binding sites localized to important regulatory regions within the -globin cluster. These sites include
MARs or ATC sequence-rich regions in HS2 (but not HS3 or HS4) and in the downstream -, -and -globin genes 12, 14, 15, 42, 43 . It has been suggested that SATB1 may participate in a dynamic process to mediate looping of the -globin locus to achieve transcriptional control, advancing the notion that SATB1 binding to MARs may facilitate the remodeling of local chromatin structure and may bring distal regulatory elements in close proximity to promoters 16 . We screened these potential MARs or SATB1-binding regions 12, 14, 15, 42, 43 and found that SATB1 bound in vivo to HS2 (M1) and the -globin CBP/p300 is a cofactor for many erythroid-specific transcription factors, such as GATA-1, NF-E2 and EKLF, and can bridge activators with TBP or pol II or other components of the basal transcription machinery 1,37,38,51 . We found that SATB1 and CBP are part of a protein complex that is important for -globin activation but does not appear to require other erythroid transcription factors. While CBP alone has minimal effect onglobin promoter activity, CBP augments SATB1 activation of the -globin promoter.
Conversely, E1A blocks SATB1 induction of -globin gene expression. Adenoviral E1A
is a viral oncoprotein that can physically interact with cellular proteins, including CBP/p300, YY1 and SWI/SNF complexes, to affect cellular proliferation and differentiation, and can inhibit erythroid differentiation through sequestering CBP/p300 For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From Figure 1 only.
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